WES after LCM confirmed that tumor regions carrying frameshift mutations in either the MSH6 or MSH3 homopolymer had significantly increased SNV, InDel and overall mutation burden (Fig. 3b–d). This evidence concerns the gene MSH6 and neoplasm.